InsidersTradesSigma
한화생명 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 한화생명 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Banks sector, 한화생명 has recorded 216 insider filings. Market capitalisation: €3,328.7bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 김국진. All data is openly available.
216
Insider Decl.
n/a
Thresholds
€8,932
81 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한화생명 Hold (neutral), based on 13 analysts. Average price target: ₩5,200.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,912 of 28,065 companies
68.4
score / 100
Value95
Quality42
FCF yld·
Earn yld23%
EV/EBITDA4.5x
ROE6.2%
Gross mgn·
Net mgn4.4%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 July 2026
Declarations216 total
3,000 sharesShareKRXDART:20250825000362
25 of 216 declarations
About 한화생명
Hanwha Life is a South Korean insurance company that offers various life insurance products and financial services. It is listed on the XKRX.